Leonard Schaeffer Joins Amgen's Board of Directors Read more about Leonard Schaeffer Joins Amgen's Board of Directors
FDA Approves Innovative, First-In-Class Treatment for a Serious Complication of Chronic Kidney Disease Read more about FDA Approves Innovative, First-In-Class Treatment for a Serious Complication of Chronic Kidney Disease
Amgen Names H. Christian Fibiger, Ph.D., and Paul G. Pearson, Ph.D., As Vice Presidents to Lead Research Efforts Read more about Amgen Names H. Christian Fibiger, Ph.D., and Paul G. Pearson, Ph.D., As Vice Presidents to Lead Research Efforts
FDA Approves ENBREL for Once-Weekly Dosing Read more about FDA Approves ENBREL for Once-Weekly Dosing
Science Recognizes Amgen as a Top Employer in Annual Survey Read more about Science Recognizes Amgen as a Top Employer in Annual Survey
Long-Term Data Support Sustained Efficacy, Tolerability and Increased Vitality For Psoriatic Arthritis Patients Treated With ENBREL and Landmark Phase 3 Data Show Ankylosing Spondylitis Patients Experienced Partial Clinical Remission, Improved Pain Relief Read more about Long-Term Data Support Sustained Efficacy, Tolerability and Increased Vitality For Psoriatic Arthritis Patients Treated With ENBREL and Landmark Phase 3 Data Show Ankylosing Spondylitis Patients Experienced Partial Clinical Remission, Improved Pain Relief
Cinacalcet HCl Phase 3 Results Demonstrate Improvement in the Management of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease Read more about Cinacalcet HCl Phase 3 Results Demonstrate Improvement in the Management of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease
Aranesp(R) Administered Once Monthly Maintains Hemoglobin Levels in Patients With Chronic Kidney Disease Read more about Aranesp(R) Administered Once Monthly Maintains Hemoglobin Levels in Patients With Chronic Kidney Disease
Amgen Announces Webcast of Conference Call to Provide Financial Guidance for 2004 Read more about Amgen Announces Webcast of Conference Call to Provide Financial Guidance for 2004
